Results 271 to 280 of about 729,537 (314)
Some of the next articles are maybe not open access.
2010
The introduction of two new classes of antiemetics, the 5 hydroxytryptamine 3 receptor antagonists (5HT3 RAs) and the neurokinin1 receptor antagonists (NK1 RAs) have revolutionised the treatment of post-chemotherapy acute and delayed nausea and vomiting, and this in turn has decreased the incidence of anticipatory emesis.
openaire +2 more sources
The introduction of two new classes of antiemetics, the 5 hydroxytryptamine 3 receptor antagonists (5HT3 RAs) and the neurokinin1 receptor antagonists (NK1 RAs) have revolutionised the treatment of post-chemotherapy acute and delayed nausea and vomiting, and this in turn has decreased the incidence of anticipatory emesis.
openaire +2 more sources